cergutuzumab
alloantibody
immunoprecipitant
vobarilizumab
ziltivekimab
solitomab
toripalimab
agonistic monoclonal antibody
sasanlimab
sintilimab
pozelimab
zenocutuzumab
cedelizumab
dinutuximab
retifanlimab
vanucizumab
oportuzumab monatox
antiantibody
carlumab
reagin
monospecific
alacizumab
ublituximab
immunopanning
-mul-
intrabody
-mab
sonepcizumab
monoantibody
elotuzumab
presentation
tucotuzumab
active immunity
chromobody
immunoproteomics
antimouse
bursopentine
besilesomab
hyperimmunoglobulin
nerelimomab
antisubstance
ozoralizumab
affinity
heterophile
immunopeptide
antigenically
patritumab
antipolyvalent
immunoproteasomal
talizumab